HBV further co‐opts immune evasion by up‐regulating PD‐L1 on HCC cells, which engages PD‐1+ CD8+ T cells to dysregulate anti‐tumour immunity and accelerate hepatocarcinogenesis.17, 18, 19. Here, CD8A is linked to neoplasm.